Newbridge Financial Services Group, Inc. Mereo Biopharma Group PLC Transaction History

Newbridge Financial Services Group, Inc.

  • $275 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 24, 2024
BUY
$2.3 - $4.05 $5,060 - $8,910
2,200 Added 23.16%
11,700 $38,000
Q4 2023

Mar 28, 2024
BUY
$1.19 - $2.42 $11,305 - $22,990
9,500 New
9,500 $21,000
Q2 2023

Jul 21, 2023
BUY
$0.79 - $1.43 $1,975 - $3,575
2,500 Added 35.71%
9,500 $12,000
Q1 2023

Apr 18, 2023
BUY
$0.71 - $1.22 $2,130 - $3,660
3,000 Added 75.0%
7,000 $4,000
Q1 2021

Sep 07, 2021
BUY
$2.6 - $4.43 $10,400 - $17,720
4,000 New
4,000 $13,000

Others Institutions Holding MREO

# of Institutions
84
Shares Held
107M
Call Options Held
209K
Put Options Held
479K
View Full List

About Mereo Biopharma Group plc

MREO Quotes by TradingView
  • Ticker MREO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,986,000
  • Market Cap $419M
  • Description
  • Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...
More about MREO
Track This Portfolio

Track Newbridge Financial Services Group, Inc. Portfolio

Follow Newbridge Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email